Filing Details

Accession Number:
0000899243-21-012547
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-18 16:34:12
Reporting Period:
2021-03-17
Accepted Time:
2021-03-18 16:34:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1418863 Anthony Pare 101 Hartwell Avenue
Lexington MA 02421
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-17 9,620 $1.84 31,612 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.80 to $1.89. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote